The complex genetics of hypoplastic left heart syndrome.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Xiaoqin, Yagi Hisato, Saeed Shazina, Bais Abha S, Gabriel George C, Chen Zhaohan, Peterson Kevin A, Li You, Schwartz Molly C, Reynolds William T, Saydmohammed Manush, Gibbs Brian, Wu Yijen, Devine William, Chatterjee Bishwanath, Klena Nikolai T, Kostka Dennis, de Mesy Bentley Karen L, Ganapathiraju Madhavi K, Dexheimer Phillip, Leatherbury Linda, Khalifa Omar, Bhagat Anchit, Zahid Maliha, Pu William, Watkins Simon, Grossfeld Paul, Murray Stephen A, Porter George A, Tsang Michael, Martin Lisa J, Benson D Woodrow, Aronow Bruce J, Lo Cecilia W
Аннотация
Congenital heart disease (CHD) affects up to 1% of live births. Although a genetic etiology is indicated by an increased recurrence risk, sporadic occurrence suggests that CHD genetics is complex. Here, we show that hypoplastic left heart syndrome (HLHS), a severe CHD, is multigenic and genetically heterogeneous. Using mouse forward genetics, we report what is, to our knowledge, the first isolation of HLHS mutant mice and identification of genes causing HLHS. Mutations from seven HLHS mouse lines showed multigenic enrichment in ten human chromosome regions linked to HLHS. Mutations in Sap130 and Pcdha9, genes not previously associated with CHD, were validated by CRISPR-Cas9 genome editing in mice as being digenic causes of HLHS. We also identified one subject with HLHS with SAP130 and PCDHA13 mutations. Mouse and zebrafish modeling showed that Sap130 mediates left ventricular hypoplasia, whereas Pcdha9 increases penetrance of aortic valve abnormalities, both signature HLHS defects. These findings show that HLHS can arise genetically in a combinatorial fashion, thus providing a new paradigm for the complex genetics of CHD.